918 publications from this institution
Book Review| June 01 1987 Oxygen Free Radicals in Shock Oxygen Free Radicals in Shock. G. P. NOVELLI, F. URSINI. KargerBasel 1986, pp. 248, £62.80 B. HALLIWELL B. HALLIWELL Search for other works by this author on: This Site PubMed Google Scholar Author and article information Publisher: Portland Press Ltd Online ISSN: 1470-8752 Print ISSN: 0300-5127 © 1987 Biochemical Society1987 Biochem Soc Trans (1987) 15 (3): 570. https://doi.org/10.1042/bst0150570a Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Cite Icon Cite Get Permissions Citation B. HALLIWELL; Oxygen Free Radicals in Shock. Biochem Soc Trans 1 June 1987; 15 (3): 570. doi: https://doi.org/10.1042/bst0150570a Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsBiochemical Society Transactions Search Advanced Search This content is only available as a PDF. © 1987 Biochemical Society1987 Article PDF first page preview Close Modal You do not currently have access to this content.
ABSTRACT Ergothioneine (ET) is a naturally occurring thiol/thione that possesses several cytoprotective properties. Multiple studies suggest a potential neuroprotective role for ET. Here, we show in various Parkinson's disease (PD) models that ET is indeed neuroprotective. Firstly, using Drosophila genetic PD models, we demonstrated that ET treatment ameliorates the pathological phenotypes of parkin and LRRK2 PD mutant flies. This includes an improvement in their climbing score and the preservation of their dopaminergic neuronal number and mitochondrial integrity. Similarly, we observed the rescue of PD phenotypes by ET in mice treated with the Parkinsonian neurotoxin 6‐OHDA. This protective effect of ET is abolished in mice lacking OCTN1. Finally, we found that ET protects human LRRK2‐G2019S patient‐derived dopaminergic neurons from rotenone‐induced neurotoxicity; the action of ET is again OCTN1‐dependent. Collectively, our results strongly support a neuroprotective role for ET in PD and suggest that ET may be useful in the prevention and/or treatment of PD. image